source
- FDA clears Edwards' tricuspid valve repair device; Bayer's blood thinner asundexian approved in ChinaThe U.S. Food and Drug Administration has granted approval for Edwards Lifesciences' new tricuspid valve repair system, expanding treatment options for patients with tricuspid regurgitation. In Ch…
- Manufacturing hurdles grow as next-gen protein therapeutics gain tractionCytiva's sponsored piece highlights growing interest in next-generation protein-based drugs such as antibody-drug conjugates, multispecific antibodies, fragments and synthetic peptides. These moda…